Search Results - "Stein, Steven"

HLA-DQA102:01 Is a Major Risk Factor for Lapatinib-Induced Hepatotoxicity in Women With Advanced Breast Cancer by SPRAGGS, Colin F, BUDDE, Laura R, CARDON, Lon R, BRILEY, Linda P, NAN BING, COX, Charles J, KING, Karen S, WHITTAKER, John C, MOOSER, Vincent E, PRESTON, Alaknanda J, STEIN, Steven H

“…Hepatobiliary adverse events (AEs) have been observed in a small proportion of patients with metastatic breast cancer (MBC) treated with lapatinib. This study…”
Get full text

Phase III, Double-Blind, Randomized Study Comparing Lapatinib Plus Paclitaxel With Placebo Plus Paclitaxel As First-Line Treatment for Metastatic Breast Cancer by DI LEO, Angelo, GOMEZ, Henry L, WILLIAMS, Lisa S, DERING, Judy, FINN, Richard S, PRESS, Michael F, AZIZ, Zeba, ZVIRBULE, Zanete, BINES, Jose, ARBUSHITES, Michael C, GUERRERA, Stephanie F, KOEHLER, Maria, OLIVA, Cristina, STEIN, Steven H

“…Lapatinib, a dual tyrosine kinase inhibitor of epidermal growth factor receptor (EGFR/ErbB1) and human epidermal growth factor receptor 2 (HER-2/ErbB2), is…”
Get full text

Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer by Stephen Johnston, John Pippen, Jr, Xavier Pivot, Mikhail Lichinitser, Saeed Sadeghi, Veronique Dieras, Henry Leonidas Gomez, Gilles Romieu, Alexey Manikhas, M. John Kennedy, Michael F. Press, Julie Maltzman, Allison Florance, Lisa O'Rourke, Cristina Oliva, Steven Stein, Mark Pegram

“…Cross-talk between human epidermal growth factor receptors and hormone receptor pathways may cause endocrine resistance in breast cancer. This trial evaluated…”
Get full text

Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer by Geyer, Charles E, Forster, John, Lindquist, Deborah, Chan, Stephen, Chan, Arlene, Romieu, C. Gilles, Pienkowski, Tadeusz, Jagiello-Gruszfeld, Agnieszka, Crown, John, Kaufman, Bella, Skarlos, Dimosthenis, Campone, Mario, Davidson, Neville, Berger, Mark, Oliva, Cristina, Rubin, Stephen D, Stein, Steven, Cameron, David

“…Trastuzumab, a humanized monoclonal antibody against the extracellular portion of human epidermal growth factor receptor type 2 (HER2), is effective in…”
Get full text

Interventional analytics in skilled nursing facilities associated with reduced readmissions by Kaknes, Derek A, Barbour, Tanner B, Ji, Wenyan, Stein, Steven M, Naylor, Mary D, Hanlon, Alexandra L

“…To assess differences in longitudinal profiles for 30-day risk-adjusted readmission rates in skilled nursing facilities (SNFs) associated with Penn Medicine's…”
Get full text

Efficacy and Safety of Lapatinib As First-Line Therapy for ErbB2-Amplified Locally Advanced or Metastatic Breast Cancer by GOMEZ, Henry L, DOVAL, Dinesh C, CASEY, Michelle A, BERGER, Mark S, STEIN, Steven H, SLEDGE, George W, CHAVEZ, Miguel A, ANG, Peter C. S, AZIZ, Zeba, NAG, Shona, NG, Christina, FRANCO, Sandra X, CHOW, Louis W. C, ARBUSHITES, Michael C

“…This study (EGF20009) assessed the efficacy and tolerability of two lapatinib administration schedules as first-line monotherapy in women with ErbB2-amplified…”
Get full text

Development and Validation of an Improved Hardiness Measure: The Hardiness Resilience Gauge by Bartone, Paul T., McDonald, Kelly, Hansma, Braden J., Stermac-Stein, Jonathan, Escobar, E. M. Romero, Stein, Steven J., Ryznar, Rebecca

“…Previous research shows that psychological hardiness is an important factor contributing to stress resilience in individuals. Of the various instruments…”
Get full text

Modernizing Eligibility Criteria for Molecularly Driven Trials by Kim, Edward S, Bernstein, David, Hilsenbeck, Susan G, Chung, Christine H, Dicker, Adam P, Ersek, Jennifer L, Stein, Steven, Khuri, Fadlo R, Burgess, Earle, Hunt, Kelly, Ivy, Percy, Bruinooge, Suanna S, Meropol, Neal, Schilsky, Richard L

“…As more clinical trials of molecularly targeted agents evolve, the number of eligibility criteria seems to be increasing. The importance and utility of…”
Get full text

Drug Insight: intracellular inhibitors of HER2-clinical development of lapatinib in breast cancer by Cameron, David A, Stein, Steven

“…There are few treatment options for patients with metastatic HER2-positive breast cancer who are unresponsive to trastuzumab. The combination of lapatinib and…”
Get full text

Lapatinib antitumor activity is not dependent upon phosphatase and tensin homologue deleted on chromosome 10 in ErbB2-overexpressing breast cancers by WENLE XIA, HUSAIN, Intisar, LEIHUA LIU, BACUS, Sarah, SAINI, Shermini, SPOHN, Janice, PRY, Karen, WESTLUND, Ron, STEIN, Steven H, SPECTOR, Neil L

“…Trastuzumab antitumor activity in ErbB2-overexpressing breast cancers seems to be dependent upon the presence of phosphatase and tensin homologue deleted on…”
Get full text

HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer by PRESS, Michael F, FINN, Richard S, DANENBERG, Kathy, MARTIN, Anne Marie, WILLIAMS, Lisa, OLIVA, Cristina, STEIN, Steven, GAGNON, Robert, ARBUSHITES, Michael, KOEHLER, Maria T, CAMERON, David, DI LEO, Angelo, GEYER, Charles E, VILLALOBOS, Ivonne E, SANTIAGO, Angela, GUZMAN, Roberta, GASPARYAN, Armen, YANLING MA

“…Purpose: Biomarkers from two randomized phase III trials were analyzed to optimize selection of patients for lapatinib therapy. Experimental Design: In…”
Get full text

4(1H)-Quinolones with Liver Stage Activity against Plasmodium berghei by LACRUE, Alexis N, SAENZ, Fabián E, CROSS, R. Matthew, UDENZE, Kenneth O, MONASTYRSKYI, Andrii, STEIN, Steven, MUTKA, Tina S, MANETSCH, Roman, KYLE, Dennis E

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Lapatinib plus capecitabine versus capecitabine alone for HER2+ (ErbB2+) metastatic breast cancer: quality-of-life assessment by Zhou, Xiaolei, Cella, David, Cameron, David, Amonkar, Mayur M, Segreti, Anthony, Stein, Steven, Walker, Mel, Geyer, Charles E

“…The randomized phase III trial EGF100151 demonstrated that the combination of lapatinib plus capecitabine (L + C) significantly improved time to progression…”
Get full text

The Student EQ Edge: Emotional Intelligence and Your Academic and Personal Success by Stein, Steven J, Book, Howard E, Kanoy, Korrel

“…Many students who are intellectually capable of succeeding have difficulties with a variety of non-cognitive competencies such as time and stress management,…”
Get full text

Emotional intelligence of leaders: a profile of top executives by Stein, Steven J., Papadogiannis, Peter, Yip, Jeremy A., Sitarenios, Gill

“…Purpose - The purpose of this paper is to examine the emotional intelligence (EI) scores of two high profile executive groups in comparison with the general…”
Get full text

Update in oncology by STEIN, Steven H

Get full text

Update in oncology by Stein, Steven H

Get full text

Can the Purse Improve Radiology Results? by Stein, Steven H

Get full text

Can the Purse Improve Radiology Results? by Stein, Steven H

Get full text

Development of a Broad-Based Pollen Identification Dataset via Genomic and Image Analyses by Novick, Roey, Elisha, Shira, Koppel, Abigail, Stein, Steven, Bielory, Leonard

Get full text